| 前收市價 | 172.36 |
| 開市 | 172.34 |
| 買盤 | 172.36 x 1100 |
| 賣出價 | 172.43 x 1100 |
| 今日波幅 | 172.36 - 172.36 |
| 52 週波幅 | 21.83 - 172.46 |
| 成交量 | |
| 平均成交量 | 952,950 |
| 市值 | 6.566B |
| Beta 值 (5 年，每月) | 1.42 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.60 |
| 業績公佈日 | 2023年11月06日 - 2023年11月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 172.42 |
Insider MonkeyShould You Add Reata Pharmaceuticals (RETA) to Your Portfolio?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here. In the second quarter, the strategy underperformed the Russell 2000 Growth Index and returned 2.50% (net), and the index return was 7.05%. Consumer Staples, Health Care, Industrials, and Information […]
InvestorPlaceThe 7 Most Promising Momentum Stocks to Own Now
Today’s volatile market makes momentum investing a compelling strategy for those comfortable with daily turbulence. Unlike value investing, which is rooted in purchasing undervalued assets, momentum investing hinges on the principle that assets that have performed well recently will continue to do so in the near future. Bottom line, momentum investing is all about capitalizing on stock market ‘hot streaks.’ Here you’ll find 7 promising momentum stock picks. Rapid advancements in artificial intel
InvestorPlaceThe 3 Most Promising Pharma Stocks to Own Now
It is remarkable that day after day there are pharmaceutical companies working hard, researching and developing high-tech medicines for the improvement of human health and the treatment of severe diseases. These companies not only do a good job of researching and developing cures, but they also have an incredible financial performance. If you are interested in the sector here are 3 promising pharma stocks, let’s take a look. Eli Lilly (LLY) Source: Jonathan Weiss / Shutterstock.com Eli Lilly (NY
